Menlo Park, Calif., July 30, 2014 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the second quarter ended June 30, 2014, on Monday, August 11, 2014, after the market close. Geron’s management will also host a conference call for analysts and investors on Monday August 11, 2014, at 4:30 p.m. Eastern Time to discuss the company’s second quarter results and recent events.
Participants can access the conference call live via telephone by dialing 866-277-1184 (U.S.); 617-597-5360 (international). The passcode is 52570360. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/f44w6tg8/lan/en . The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through September 12, 2014.
About Geron
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
Help employers find you! Check out all the jobs and post your resume.
